Park Chan Soon, Choi Eue-Keun, Lee So-Ryoung, Ahn Hyo-Jeong, Kwon Soonil, Kim Sunhwa, Sohn Suk Ho, Choi Jae Woong, Hwang Ho Young, Oh Seil
Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Front Cardiovasc Med. 2022 Sep 23;9:881831. doi: 10.3389/fcvm.2022.881831. eCollection 2022.
Pulmonary vein antrum isolation (PVAI) is the cornerstone of atrial fibrillation (AF) ablation, but the clinical outcomes of PVAI are unsatisfactory in patients with persistent AF and a large left atrium (LA).
We investigated the clinical outcomes following radiofrequency ablation (RFCA), cryoballoon ablation (CBA), and thoracoscopic maze in patients with persistent AF and a large LA.
We included patients with consecutive persistent AF who had a large LA (LA diameter >50 mm) and underwent RFCA, CBA, or thoracoscopic maze surgery. In the RFCA group, additional linear ablation was performed at the physician's discretion. The endpoint was 12 months without recurrence of an atrial arrhythmia, including AF, atrial flutter, and atrial tachycardia, following a 90-day blanking period.
We recruited 89 persistent AF patients with a large LA who underwent RFCA ( = 32), CBA ( = 38), or the thoracoscopic maze procedure ( = 19). During the 12-month follow-up, 48 (53.9%) cases of AF recurrence were observed. There was no prognostic difference between groups (50.0% in RFCA vs. 52.6% in CBA vs. 63.2% in thoracoscopic maze, all > 0.05). Early recurrence during the blanking period was a significant predictor of late recurrence for RFCA and CBA, but not for the thoracoscopic maze.
In persistent AF patients with a large LA, we did not find a prognostic difference RFCA, CBA, or a thoracoscopic maze procedure in recurrence of atrial arrhythmia. Early recurrence predicted late recurrence in catheter ablation, but not in thoracoscopic maze.
肺静脉前庭隔离术(PVAI)是心房颤动(AF)消融的基石,但对于持续性AF和左心房(LA)增大的患者,PVAI的临床疗效并不理想。
我们研究了持续性AF和LA增大患者接受射频消融(RFCA)、冷冻球囊消融(CBA)和胸腔镜迷宫手术的临床疗效。
我们纳入了连续的持续性AF且LA增大(LA直径>50 mm)并接受RFCA、CBA或胸腔镜迷宫手术的患者。在RFCA组,根据医生的判断进行额外的线性消融。终点是在90天的空白期后12个月无房性心律失常复发,包括AF、心房扑动和房性心动过速。
我们招募了89例LA增大的持续性AF患者,他们接受了RFCA(n = 32)、CBA(n = 38)或胸腔镜迷宫手术(n = 19)。在12个月的随访期间,观察到48例(53.9%)AF复发。各组之间无预后差异(RFCA组为50.0%,CBA组为52.6%,胸腔镜迷宫手术组为63.2%,均P>0.05)。空白期的早期复发是RFCA和CBA晚期复发的重要预测因素,但不是胸腔镜迷宫手术的预测因素。
在LA增大的持续性AF患者中,我们未发现RFCA、CBA或胸腔镜迷宫手术在房性心律失常复发方面存在预后差异。导管消融中早期复发可预测晚期复发,但胸腔镜迷宫手术中并非如此。